Levi & Korsinsky, LLP announces that a CODX class action lawsuit has been filed on behalf of investors who purchased Co-Diagnostics, Inc. (CODX) securities between February 25, 2020 and May 15, 2020. For more on the CODX Lawsuit please contact us today.
According to the Co-Diagnostics, Inc. lawsuit, throughout the Class Period defendants made false and/or misleading statements and/or failed to disclose that:
According to the filed complaint, Co-Diagnostics and its directors and officers (including PhD-level scientists who should know better) made continual, knowing, and willful misstatements about the Company’s main product, a Covid-19 diagnostic test. These misstatements had the effect of pumping up the price of Co-Diagnostics’ stock while Company officers and directors exercised low-priced options and dumped their stock into the market. Co-Diagnostics’ fraudulent misstatements displayed a disregard for the basic scientific principles and cost investors to lose millions of dollars.
If you suffered a loss in Co-Diagnostics, Inc. you have until August 17, 2020 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn't require that you serve as a lead plaintiff.